Search results
Results from the WOW.Com Content Network
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare condition (1:1,000,000), in which the bones have lesions, inflammation, and pain. It is called multifocal because it can appear in different parts of the body, primarily bones, and osteomyelitis because it is very similar to that disease, although CRMO appears to be without any infection .
Treatment with tumor necrosis factor alpha antagonists (TNF inhibitors) has been tried in a few patients with limited success. [7] Other drugs that are used in psoriatic arthritis , to which SAPHO syndrome is closely related, have also been used in this condition.
Chronic recurrent multifocal osteomyelitis: LPIN2, D18S60. Synonyms: Majeed syndrome. Complement component 2 deficiency: Possibly symptomatic of autoimmune diseases, but not a disease. Congenital heart block: May be related to autoimmune activity in the mother. Contact dermatitis: A hypersensitivity. Cushing's syndrome
Treatment of the relatively rare fungal osteomyelitis as mycetoma infection entails the use of antifungal medications. [9] In contrast to bacterial osteomyelitis, amputation or large bony resections is more common in neglected fungal osteomyelitis (mycetoma) where infections of the foot account for the majority of cases.
Episodic, affecting bone (chronic recurrent multifocal osteomyelitis (CRMO)) Persistent and multisystemic (Schnitzler syndrome, Crohn's disease, or DIRA) Persistent, affecting the skin (Interleukin-36-receptor antagonist deficiency (DITRA), Sweet syndrome or neutrophilic panniculitis) [3]
An American citizen has died at a popular adventure spot in Laos where alcohol tainted with methanol has been blamed for a spate of poisonings in recent days.. The State Department said the U.S ...
The students attend Dr. James Craik Elementary School and belong to the district's ACHIEVE program, for students with "significant cognitive disabilities" and SOAR program, for students with autism.
Surgery is the main treatment, often combined with antibiotics. The prognosis is generally favorable, with minimal risk of lasting disability or recurrence. Brodie abscess is responsible for 2.5%-42% of primary bone infections. It is named after Sir Benjamin Collins Brodie, 1st Baronet, who initially described the condition in the 1830s.